Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
Published June 10, 2026 · Recall initiated: May 27, 2026
Summary
FDA records drug Class II recall D-0584-2026, published June 10, 2026 and initiated May 27, 2026. Recalling firm: Lannett Company Inc.; Status: Ongoing; Reported quantity: 3984 bottles; Lot: Lot #: 25282724A, Exp. Date 2027/01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
What to do
Voluntary: Firm initiated · Letter
Get an email if NIACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NIACIN
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0362175320469
- Lot
- Lot #: 25282724A, Exp. Date 2027/01
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured byJune 17, 2026
- FDATopCare health, ULTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 1000mg, 72 CHEWABLE TABLETS, DISTRIBUTED BYJune 10, 2026
- FDAXyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: OhmJune 10, 2026
- FDANIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers UrbanNovember 26, 2025
- FDANiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: LannettOctober 29, 2025
- FDANiacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun PharmaceuticalJanuary 31, 2024
Questions about this recall
Was Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. recalled?
Yes. FDA published recall D-0584-2026 on June 10, 2026. Reported hazard: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NIACIN. UPC: 0362175320469.